Candesartan Cilexetil Impurity 20（CAS号：170791-09-0）

三苯甲基坎地沙坦西来替昔酯

基本信息

在编辑器中查看

CAS号

170791-09-0

分子式

C52H48N6O6

分子量

852.99 g/mol

化学分类

基础化工原料有机化学品羧酸类

基础化工原料有机化学品酯类

基础化工原料有机化学品醚类

基础化工原料有机化学品杂环化合物

医药化工医药中间体杂环中间体

精细化工产品染料和颜料有机染料

精细化工产品表面活性剂阴离子表面活性剂

实验室化学品科研化学品生化试剂

基本物理性质

物理状态

Powder

熔点

180-188°C

SMILES

在编辑器中查看

CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5C(C6=CC=CC=C6)(C7=CC=CC=C7)C8=CC=CC=C8)C(=O)OC(C)OC(=O)OC9CCCCC9

InChI

InChI=1S/C52H48N6O6/c1-3-61-50-53-46-30-18-29-45(49(59)62-36(2)63-51(60)64-42-25-14-7-15-26-42)47(46)57(50)35-37-31-33-38(34-32-37)43-27-16-17-28-44(43)48-54-55-56-58(48)52(39-19-8-4-9-20-39,40-21-10-5-11-22-40)41-23-12-6-13-24-41/h4-6,8-13,16-24,27-34,36,42H,3,7,14-15,25-26,35H2,1-2H3

InChIKey

MOHQWFWIPOOTGV-UHFFFAOYSA-N

LogP

10.632699999999993

拓扑极性表面积

132.48 Å²

氢键供体/受体

0 / 12

复杂度

1410

安全信息

查看安全信息

危险说明

H315 造成皮肤刺激
皮肤腐蚀/刺激

H319 造成严重眼刺激
严重眼损伤/眼刺激

H335 可能造成呼吸道刺激
特定目标器官毒性-单次接触；呼吸道刺激

同义词与引用数据

英文

(1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate
1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
UNII-006A6A2YSO
Q27231326
SCHEMBL2477228
C73285
1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(N-triphenylmethyltetrazole-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate
(+/-)-Trityl candesartan cilexetil
C52H48N6O6
CANDESARTAN CILEXETIL IMPURITY H [EP IMPURITY]
1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(N-triphenylmethyltetrazole-5-yl)biphenyl-4-yl]methy]benzimidazole-7-carboxylate
AB42672
EC 605-586-7
(+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(N-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate
1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
AM90298
Trityl candesartan cilexetil
2-phenyl-2H-benzo[b][1,4]thiazin-3(4H)-one
006A6A2YSO
2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-7-benzimidazolecarboxylic acid 1-(cyclohexyloxycarbonyloxy)ethyl ester
Candesartan cilexetil specified impurity H [EP]
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
NS00004639
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1-(triphenylmethyl)-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester
MOHQWFWIPOOTGV-UHFFFAOYSA-N
AC-6865
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
170791-09-0
AKOS015896145
DTXSID901308612

中文

三苯甲基坎地沙坦西来替昔酯
坎地沙坦酯杂质H(EP) 标准品
三苯基坎地沙坦酯
三苯基坎地沙坦酯C10
三苯甲基坎地沙坦西酯
三苯甲基坎地沙坦酯
三苯甲基坎地沙坦酯C10
2-乙氧基-1-[[2'-(三苯甲基-1H-四氮唑-5-基)[1,1'-联苯基]-4-基]甲基]-1H-苯并咪唑-7-甲酸-1-[[(环己氧基)羰基]氧基]乙酯
三苯甲基坎地沙坦
西来替昔酯
坎地沙坦酯EP杂质H
坎地沙坦酯中间体C10
三苯甲基坎地沙昔坦(TCDC)
三苯甲基坎地沙坦西来替昔酯 C10
坎地沙坦酯EP杂质H(参见C4X-12348)
坎地沙坦酯中间体(C10)三苯甲基坎地沙坦西来替昔酯